Analytical Characterization of Polymer Components in Parenteral Primary Packaging.

Chemically crosslinked elastomers such as butyl rubber (IIR) and its halogenated derivatives (BIIR, CIIR) remain the benchmark for parenteral applications due to their exceptional gas barrier properties, chemical resistance, and long-term stability. Emerging materials, including brominated isobutylene-co-para-methylstyrene and thermoplastic elastomers (e.g., SEBS-based materials), offer architectural flexibility and processing advantages but require careful formulation to achieve equivalent sealing and barrier performance. The relationship between polymer composition, viscoelastic behavior, and functional sealing performance is examined using mechanical, thermal, rheological, and analytical characterization techniques. The paper further discusses product-level requirements, including compendial compliance, extractables and leachables (E&L) assessment with USP <1663>/<1664>, biocompatibility, and deterministic CCI testing in accordance with USP <1207> and global regulatory expectations. Special attention is given to time-dependent sealing behavior, residual seal force, pressure-induced stopper movement, and performance under cryogenic storage conditions relevant to advanced biologics and mRNA-based therapies. The evolution of risk-based extractables and leachables strategies, including threshold concepts (SCT, QT, AET) and advances in chromatographic and mass spectrometric methodologies, is also reviewed. Finally, the integration of finite element analysis, viscoelastic modeling, and mass migration simulation is presented as a predictive framework to complement empirical testing, reduce development complexity, and support science-based regulatory justification. Together, material science, analytical characterization, performance testing, and simulation-driven design form a holistic approach to developing robust, compliant, and future-ready elastomeric primary packaging components for sterile pharmaceutical products.